Vystar's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Vystar (VYST) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Vystar vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs 197,901M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-49.1% annualized vs trailing 12 months), vs holding steady (-0.7%) for its tracked peer group.
- Growth: Vystar generated -51.4% revenue growth year over year in Q1 2026, vs -3.9% for its tracked competitors combined.
- Profitability: Its -5,934.3% net margin compares with 5.7% for the peer group.
- Peer revenue share: Vystar accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.05M compares with $0.45M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
VYST Sales vs. its Competitors, Q1 2026
Vystar reported revenue contraction of 51.43 % year on year in Q1 2026, below its competitors' combined revenue change of -3.87 %.
With a net margin of -5,934.26 %, Vystar reported lower profitability than its competitors (5.73 %).
Vystar generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
Vystar vs. its Competitors, Q1 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Vystar and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Vystar Corporation | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Vystar's competitor groups requires a Commercial License.
For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs -51.4% for Vystar. Vystar's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Vystar's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Vystar Corporation | - | No | No | Yes |
| Competitors combined (28) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
VYST Stock Performance relative to its Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Dupont De Nemours Inc | 282.9% | Outperformed |
| 2 | Avadel Pharmaceuticals Plc | 282.9% | Outperformed |
| 3 | Sealed Air Corp | 282.9% | Outperformed |
| 4 | Enviri Corp | 282.9% | Outperformed |
| 5 | Ufp Technologies Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Vystar's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Vystar's Comment on Competition and Industry Peers
Publicly Traded Peers of Vystar Corporation
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Vystar Corporation | 1.94 | 0.05 |
| 3m Company | 88,019.18 | 25,180.00 |
| Illinois Tool Works Inc | 76,649.09 | 16,469.00 |
| Honeywell International Inc | 66,947.42 | 36,130.00 |
| Ppg Industries Inc | 23,790.89 | 16,121.00 |
| Dow Inc | 19,912.33 | 39,331.00 |
| SUBTOTAL | 375,806.62 | 203,509.57 |
Sign in to see all competitors of Vystar Corporation.
Sources: Vystar Corporation's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Vystar Corporation versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Vystar's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Rotmans | Named by the company | 85% |
| RxAir | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Vystar's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Vystar's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| 3m Company | Safety and Industrial 47.55 % |
| Illinois Tool Works Inc | Automotive OEM 20.42 % |
| Ppg Industries Inc | Industrial Coatings 39.69 % |
| Dupont De Nemours Inc | Diversified Industrials 52.94 % |
| Avery Dennison Corporation | Materials Group 69.81 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Vystar Corporation.
Vystar's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Vystar Corporation | 2 | 48,311 | -1,358,347 |
| 3m Company | 88,019 | 416,198 | 49,785 |
| Illinois Tool Works Inc | 76,649 | 383,000 | 74,279 |
| Honeywell International Inc | 66,947 | 357,723 | 81,356 |
| Ppg Industries Inc | 23,791 | 370,598 | 36,759 |
| Dow Inc | 19,912 | 1,136,734 | -75,116 |
| PEERS TOTAL | 375,805 | 449,041 | 37,877 |
Sign in to see all peers for Vystar Corporation.
Vystar's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| 3m Company | Americas 54.09 % |
| Ppg Industries Inc | North America 35.64 % |
| Dupont De Nemours Inc | United States 44.47 % |
| Rpm International Inc | US 68.55 % |
| Axalta Coating Systems Ltd | EMEA 35.94 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Vystar's Position in Industry Market Structure
Market-capitalization share and concentration across all 222 companies in Vystar's industry classification, broader than the peer set above. Market cap in millions of $.Vystar ranks #0 of 222 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 586, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Intuitive Surgical Inc | 147,272 | 13.43 % |
| 2 | Medtronic Plc | 111,919 | 10.21 % |
| 3 | Stryker Corp | 107,636 | 9.82 % |
| 4 | 3m Company | 88,019 | 8.03 % |
| 5 | Boston Scientific Corporation | 1,234 | 5.2% |
| 6 | Edwards Lifesciences Corporation | 1,234 | 5.2% |
| 7 | Becton Dickinson And Company | 1,234 | 5.2% |
| 8 | Dexcom Inc | 1,234 | 5.2% |
| 9 | Resmed Inc | 1,234 | 5.2% |
| 10 | Alcon inc | 1,234 | 5.2% |
| 0 | Vystar Corporation | 2 | 0.00 % |
Market cap and industry share for the rest of Vystar's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-29.
Vystar's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Medical Equipment & Supplies industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (288 companies). See the full Medical Equipment & Supplies industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 65.78 % | 53.36 % (avg) | +12.4 pp |
| Operating Margin | - | industry median | - |
| EBITDA Margin | - | -6.79 % (avg) | - |
| Capital Intensity (Capex / Revenue) | - | 5.43 % (avg) | - |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Vystar's Valuation vs Competitive Position
Valuation multiples vs the Medical Equipment & Supplies industry average (288 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Medical Equipment & Supplies industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 34.6x | - |
| EV / EBITDA | - | 19.7x | - |
| P/B | -0.2x | 4.7x | -5.0x |
| Return on Equity | 21.08 % | industry aggregate | 12.79 % |
| Return on Invested Capital | 7.74 % | -2.30 % (avg) | 10.04 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Vystar's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 500.00 % | 500.00 % | 53.29 % | 31.79 % | -68.44 % | -95.00 % | -74.14 % | -59.68 % |
| Operating Margin | -1,086.13 % | -36.10 % | -21.94 % | -15.86 % | -33.78 % | - | - | - |
| Return on Invested Capital | 229.83 % | -58.79 % | -48.24 % | -42.88 % | -55.13 % | 39.13 % | 9.46 % | 8.56 % |
| P/E | - | - | - | - | - | - | 0.5x | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Vystar's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 586 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Vystar's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Vystar's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Vystar's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Return on equity 12.8 points above the industry aggregate.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-49.1% annualized vs trailing 12 months).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Vystar's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Vystar Corporation | 0.00 | 0.06 | - |
| 3m Company | - | 1.57 | 3.20 |
| Illinois Tool Works Inc | 0.17 | 1.24 | 2.93 |
| Honeywell International Inc | 0.51 | 1.31 | 2.10 |
| Ppg Industries Inc | 0.34 | 1.52 | 0.91 |
| Dow Inc | 0.37 | 1.86 | 0.99 |
Sign in to see all peers for Vystar Corporation.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Vystar's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Vystar Corporation | Q1 2026 | -51.4 % | - |
| 3m Company | Q2 2026 | +2.5 % | +29.4 % |
| Illinois Tool Works Inc | Q2 2026 | +6.1 % | +7.9 % |
| Honeywell International Inc | Q2 2026 | -6.1 % | +262.4 % |
| Ppg Industries Inc | Q1 2026 | +6.7 % | +1.9 % |
| Dow Inc | Q1 2026 | -6.1 % | - |
| PEERS TOTAL | -2.9 % | +134.6 % |
Sign in to see all peers for Vystar Corporation.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Vystar's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Vystar Corporation | Q1 2026 | -77.5 % | - |
| 3m Company | Q2 2026 | +4.7 % | +7.2 % |
| Illinois Tool Works Inc | Q2 2026 | -10.5 % | -8.9 % |
| Honeywell International Inc | Q2 2026 | +7.2 % | +39.4 % |
| Ppg Industries Inc | Q1 2026 | +6.2 % | -6.2 % |
| Dow Inc | Q1 2026 | -6.2 % | -26.7 % |
Sign in to see all peers for Vystar Corporation.
Vystar's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Vystar Corporation | - | - | - |
| 3m Company | 8.27% | 11.16% | 76.55% |
| Illinois Tool Works Inc | 19.64% | 26.49% | 101.72% |
| Honeywell International Inc | 10.74% | 17.01% | 49.57% |
| Ppg Industries Inc | 7.23% | 9.42% | 19.96% |
| Dow Inc | - | - | - |
Sign in to see all peers for Vystar Corporation.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Vystar's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Vystar Corporation | - | 40.21 |
| 3m Company | 29.93 | 3.50 |
| Illinois Tool Works Inc | 35.56 | 4.65 |
| Honeywell International Inc | 8.26 | 1.85 |
| Ppg Industries Inc | 15.15 | 1.48 |
| Dow Inc | - | 0.51 |
| PEERS AVERAGE | 21.89 | 1.85 |
Sign in to see all peers for Vystar Corporation.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.